Product Code: ETC340821 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Pneumonia Vaccine market in China is growing due to the rising prevalence of pneumonia and the need for effective vaccination to prevent the disease. Pneumonia vaccines are essential for reducing the incidence of pneumonia and protecting public health. The market is driven by advancements in vaccine development and increasing healthcare awareness. Chinese pharmaceutical companies are investing in research and development to provide effective pneumonia vaccines and meet the needs of the healthcare sector.
The Pneumonia Vaccine market in China is influenced by the demand for vaccines that prevent pneumonia, a serious respiratory infection. Pneumonia vaccines offer benefits such as reduced incidence of pneumonia, improved public health, and protection against various strains of bacteria. Market growth is supported by increasing awareness of vaccine benefits, advancements in vaccine development, and the need for effective preventive measures in healthcare.
The pneumonia vaccine market faces challenges related to regulatory approval and public health policies. Obtaining regulatory approval for new vaccines requires rigorous testing and compliance with health standards, which can be time-consuming and costly. Additionally, market dynamics are influenced by public health policies and vaccination programs.
The pneumonia vaccine market in China is shaped by government policies related to public health and vaccine safety. The government establishes standards for the production and use of pneumonia vaccines to ensure they meet industry requirements. Policies support the development and integration of advanced vaccine technologies through funding and research incentives and address concerns related to vaccine safety and efficacy.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Pneumonia Vaccine Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Pneumonia Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 China Pneumonia Vaccine Market - Industry Life Cycle |
3.4 China Pneumonia Vaccine Market - Porter's Five Forces |
3.5 China Pneumonia Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 China Pneumonia Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 China Pneumonia Vaccine Market Revenues & Volume Share, By Sector, 2021 & 2031F |
3.8 China Pneumonia Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Pneumonia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in China |
4.2.2 Government initiatives to improve healthcare infrastructure |
4.2.3 Rising incidences of pneumonia cases in China |
4.3 Market Restraints |
4.3.1 High cost of pneumonia vaccines |
4.3.2 Challenges in distribution and access to rural areas in China |
5 China Pneumonia Vaccine Market Trends |
6 China Pneumonia Vaccine Market, By Types |
6.1 China Pneumonia Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 China Pneumonia Vaccine Market Revenues & Volume, By Vaccine Type, 2021-2031F |
6.1.3 China Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021-2031F |
6.1.4 China Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021-2031F |
6.2 China Pneumonia Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 China Pneumonia Vaccine Market Revenues & Volume, By Prevnar 13, 2021-2031F |
6.2.3 China Pneumonia Vaccine Market Revenues & Volume, By Synflorix, 2021-2031F |
6.2.4 China Pneumonia Vaccine Market Revenues & Volume, By Pneumovax 23, 2021-2031F |
6.3 China Pneumonia Vaccine Market, By Sector |
6.3.1 Overview and Analysis |
6.3.2 China Pneumonia Vaccine Market Revenues & Volume, By Public, 2021-2031F |
6.3.3 China Pneumonia Vaccine Market Revenues & Volume, By Private, 2021-2031F |
6.4 China Pneumonia Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 China Pneumonia Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021-2031F |
6.4.3 China Pneumonia Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021-2031F |
6.4.4 China Pneumonia Vaccine Market Revenues & Volume, By Government Authorities, 2021-2031F |
7 China Pneumonia Vaccine Market Import-Export Trade Statistics |
7.1 China Pneumonia Vaccine Market Export to Major Countries |
7.2 China Pneumonia Vaccine Market Imports from Major Countries |
8 China Pneumonia Vaccine Market Key Performance Indicators |
8.1 Immunization coverage rate for pneumonia vaccines in China |
8.2 Number of government-funded vaccination programs targeting pneumonia |
8.3 Research and development investments in pneumonia vaccine technology |
9 China Pneumonia Vaccine Market - Opportunity Assessment |
9.1 China Pneumonia Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 China Pneumonia Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 China Pneumonia Vaccine Market Opportunity Assessment, By Sector, 2021 & 2031F |
9.4 China Pneumonia Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Pneumonia Vaccine Market - Competitive Landscape |
10.1 China Pneumonia Vaccine Market Revenue Share, By Companies, 2024 |
10.2 China Pneumonia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |